Search research articles
Contact Us
Filters
Showing results (21-30 of 125) with videos related to
Page
of 13
Sort By:
British Journal of Clinical Pharmacology
|
September 14, 2016
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients
Evelien J M Kuip, Maarten L Zandvliet, Stijn L W Koolen, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 11, 2024
Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma
Barend J Sikkema, Ron H J Mathijssen, Debbie G J Robbrecht, et al.
British Journal of Cancer
|
November 26, 2024
Effects of tamoxifen on cognitive function in patients with primary breast cancer
Maryse J Luijendijk, Sanne M Buijs, Agnes Jager, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 13, 2023
Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS
Simon P de Leeuw, Peter de Bruijn, Stijn L W Koolen, et al.
The Oncologist
|
September 4, 2009
Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature
Stijn L W Koolen, Alwin D R Huitema, Robert S Jansen, et al.
Drugs
|
May 24, 2025
A Clinical Pharmacological Perspective on Intraperitoneal Chemotherapy
Pascale C S Rietveld, Niels A D Guchelaar, Sebastiaan D T Sassen, et al.
EJNMMI Radiopharmacy and Chemistry
|
February 20, 2025
Ac-225 radiochemistry through the lens of [<sup>225</sup>Ac]Ac-DOTA-TATE
Eline L Hooijman, Jan R de Jong, Carolline M Ntihabose, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 4, 2019
Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application
C Louwrens Braal, G D Marijn Veerman, Robert Peric, et al.
Therapeutic Drug Monitoring
|
September 24, 2025
Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs: Achievements, Experiences, Challenges, and the Path Forward
Maud B A van der Kleij, Karolijn W M Groot Beumer, Stijn L W Koolen, et al.
Clinical Drug Investigation
|
January 12, 2022
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial
C Louwrens Braal, Anne Kleijburg, Agnes Jager, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 125) with videos related to
Sort By:
Page
of 13
British Journal of Clinical Pharmacology
|
September 14, 2016
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients
Evelien J M Kuip, Maarten L Zandvliet, Stijn L W Koolen, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 11, 2024
Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma
Barend J Sikkema, Ron H J Mathijssen, Debbie G J Robbrecht, et al.
British Journal of Cancer
|
November 26, 2024
Effects of tamoxifen on cognitive function in patients with primary breast cancer
Maryse J Luijendijk, Sanne M Buijs, Agnes Jager, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 13, 2023
Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS
Simon P de Leeuw, Peter de Bruijn, Stijn L W Koolen, et al.
The Oncologist
|
September 4, 2009
Pharmacokinetics of gemcitabine and metabolites in a patient with double-sided nephrectomy: a case report and review of the literature
Stijn L W Koolen, Alwin D R Huitema, Robert S Jansen, et al.
Drugs
|
May 24, 2025
A Clinical Pharmacological Perspective on Intraperitoneal Chemotherapy
Pascale C S Rietveld, Niels A D Guchelaar, Sebastiaan D T Sassen, et al.
EJNMMI Radiopharmacy and Chemistry
|
February 20, 2025
Ac-225 radiochemistry through the lens of [<sup>225</sup>Ac]Ac-DOTA-TATE
Eline L Hooijman, Jan R de Jong, Carolline M Ntihabose, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 4, 2019
Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application
C Louwrens Braal, G D Marijn Veerman, Robert Peric, et al.
Therapeutic Drug Monitoring
|
September 24, 2025
Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs: Achievements, Experiences, Challenges, and the Path Forward
Maud B A van der Kleij, Karolijn W M Groot Beumer, Stijn L W Koolen, et al.
Clinical Drug Investigation
|
January 12, 2022
Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial
C Louwrens Braal, Anne Kleijburg, Agnes Jager, et al.
Page
of 13